INTRODUCTION:

One of the assets that nature has bestowed mankind with for the advancement of novel medicines is the pharmacophores and chemotypes. Therapeutic spices have extended around the world and, as of late, have happened to have fundamental significance in treating sicknesses. Their helpful job is given by their bioactive atoms and the different parts of the plant. From the time of antiquated occasions, normal mixtures have assumed a significant part in the treatment procedure and avoidance of the pathology, shaping the foundation of the customary means of mending.

Besides, earthbound plants (for example Curcuma longa L., Artemisia annua L., Gingko biloba L., Camptotheca acuminata Decne., Podophyllum peltatum L., Taxus baccata, Taxus brevifolia, Combretum caffrum, Euphorbia peplus, and so forth) nowadays have been ruling restorative methodologies, as the plant-inferred compounds contain a massive part of present drug specialists, quite eminently in the space chemotherapy.^1-3

The occupation of customary combinations as prescriptions or as a justification behind the progression of new drugs is completely explained in the most recent review disseminated by Newman and Cragg. According to their data, out of a total of 1881 new upheld prescriptions (antiviral, antibacterial, antifungal, antiparasitic, antitumor, etc.) over the latest forty years, 929 have ordinary start what's more fall into the class of natural macromolecules, unaltered regular items, plant medications, or subsidiaries of normal items or immunizations, while the other 952 medications are named engineered drugs, manufactured medications with normal item pharmacophores or as medications that copy a characteristic item.^4-6

The use of regular prescriptions has been by and large embraced as a basic or elective decision in the oncology field (Catharanthus roseus, Podophyllum peltatum L., Taxus brevifolia Nutt., Taxus baccata, etc).⁷ Subsequently, reliably, a couple of novel cytotoxic combinations are detached from plants and include extra open doors to fight harmful development. Numerous analysts place their consideration on the examination of normally happening atomic substances that may become valuable to the drug business.⁸ The people who find compounds applying antitumor movement during preclinical investigations search out for clinical adequacy affirmation as well. The job of regular mixtures as medications or as a reason for the advancement of new medications is clarified in the latest survey distributed by Newman and Cragg. As per their information, new supported medications (antibacterial, antifungal, antiviral, antiparasitic, antitumor, and so on) over the most recent forty years, 929 have a normal beginning and belong to the organic macromolecule's class, unchanged regular items, plant medications, or subsidiaries of normal items or immunizations, while the other 952 medications are named engineered drugs, manufactured medications with normal item pharmacophores or as medications that copy a characteristic item.^9-10

Carcinogenesis, the wonder of malignancy emerging and creating, is a bit by bit measure portrayed by the movement of particular atomic changes aggregation of transformations and epigenetic modifications that actuate oncogenes, inactivation of growth silencer qualities, impediment of DNA fix hardware and disturbance of apoptosis systems, which constrains cells to go through uncontrolled cell division. A solitary adjustment can't advance tumorigenesis, yet an assortment of various changes that influence cell homeostasis is important to cause cells to fail to keep a grip on expansion.¹¹ With every aggravation, cells go through basic changes, prompting cancer inception, advancement, and movement. Cancer inception is a quick and irreversible cycle that starts with the openness of a cancer-causing specialist, trailed by its transfer to the tissues where it results in DNA changes.¹² Concerning treatment, conclusive growth annihilation through careful resection, radiation treatment, immunotherapy, and chemotherapy keeps on being important for the current backbone therapy regimens.^13-15 In any case, the anticipation of carcinogenesis is profoundly desirable over therapy, as malignant growth is generally a preventable sickness that can be credited to the way of life factors (like tobacco smoking, nourishment status, etc.). Chemoprevention is acquiring consideration by people particularly because it is savvy and maintains a strategic distance from the harmful incidental effects following malignancy treatment.¹⁶

The advantages of regular mixtures as diminished unfavorable impacts and the ability to affect different flagging pathways engaged with the carcinogenesis interaction could be viewed as a clarification for the way that from 240 antitumor medications supported over the most recent 40 years; just 29 are completely manufactured medications. Besides, in the beyond 10 years, manufactured mixtures with pharmacophore of regular beginning that mirror the normal item impact were supported as antitumor medications.¹⁷

The spotlight of breast cancer research has phytochemicals from the time of its initial beginnings, being the main antineoplastic medications found (e.g., leucovorin (1950), carzinophilin (1954), vincristine (1963), actinomycin D (1964), and so on).¹⁸Moreover, their review proceeded to the current day. It is critical to refer to that normal mixtures fill in as chemotherapeutic specialists, yet in addition as adjuvants in malignant growth treatment. Breast cancer growth is a significant general medical issue overall, which is the second most normal disease analyzed and is likewise a superb explanation of death in ladies all around the world.¹⁹ It has turned into a deadly sickness, and hazard factors related to bosom malignancy appear to extend step by step .To confront this destructive circumstance, many examination works are presently planned dedicatedly to discover the elective therapy arrangement of bosom disease utilized as therapeutics, as an adjuvant therapy other than different medicines, or as chemo-preventive specialists. The root cause of bosom disease or breast cancer and the expansion of malignant cells is interceded by various components or pathways. Again there are various biomarkers utilized for the demonstrative cycle. ^20-22

Any of these components can be adopted as a treatment approach by obtaining them from a regular sourcePertinent therapy techniques for patients of bosom malignant growth of breast cancer incorporate a medical procedure, radiotherapy with adjuvant chemotherapy, and chemical treatment which can give positive criticism. Although it lessens the danger of death and reemission, it has been accounted for that there can be a frequency of brachial plexopathy, tissue rot, rib break, pericarditis, and second non-breast malignancies happening in patients with early-stage breast cancer treated with surgery and radiation treatment.^23-25

In the event of TNBC therapy, the main effective and fundamental treatment is "chemotherapy" with a danger of multidrug resistance (MDR) growths where the body creates protection from therapy by use of multiple medications and are an intense reason for malignancy-related passings in persistent.²⁶ Moreover, vital symptoms of chemotherapy might prompt the reduction of platelets, both red and white platelets along these lines increasing the possibility of contamination and paleness, individually, with the cells’ diminished capacity to carry oxygen. Another huge incidental effect is balding or loss of hair coming about because of traditional treatment.²⁷ Natural mixes or phytochemicals are beneficial to one's health because they act directly on specific molecular targets or genes, or indirectly by stabilising conjugates that influence metabolic pathways. Plant-based chemicals can be used as chemotherapy adjuvants, according to Liao et al. (2013), with the purpose of reducing side effects such as tiredness, nausea, mucositis, anaemia, and frailty caused by chemotherapy.²⁸

Breast cancer is distributed into estrogen receptors both positive and negative, (ER)-positive namely MCF-7 and T47D cell lines; ER-negative namely SKBR3, MDA-MB-468, MDA-MB-231, and MDA-MB-453 cell lines) breast cancer. A recently published meta-analysis of 93 studies refocused the reports on breast cancer, with several confirming a protective effect of a balanced diet on cancer risk, particularly in postmenopausal, hormone receptor-negative women.

Thus by downregulation of ER-α expression and exertion, suppression of proliferation, metastasis, and angiogenesis of those cells, conversion of apoptosis and sensitization of breast cancer cells to radiotherapy and chemotherapy, numerous natural products and their bioactive factors showed inhibition of malignant breast cancer.²⁹

Curcumin:

Eun Yi Ko et al. (2015) Curcumin [1,7 bis (4 hydroxy 3methoxyphenyl) 1,6 heptadiene 3,5 dione] is a natural food colour derived from Curcuma longa Linn's roots. Curcumin's chemotherapeutic effects on breast cancer have been studied in a number of ways.

Curcumin inhibits breast cancer in vitro by regulating MMP 2, B-cell lymphoma 2(Bcl2), Bax, valve endonuclease 1(Fen1), NFE2-related factor 2(Nrf2), and phosphoinositide-3 kinase. In signal transduction, shown activity (PI3K)/(Akt) Protein kinase B. Curcumin inhibits HRas-mediated invasive aggregation in MCF10A human breast epithelial cells in a partly and time dependent manner (HRas MCF10A).

Lycopene:

According to Eun-Yi Ko et al. (2015), lycopene, a key carotenoid found in fruits and vegetables such as tomatoes, can also be used to cure breast cancer. In breast cancer, lycopene is linked to the ERK and Akt/mTOR signalling pathways. Activation of the ERK, IGF and Akt signalling pathways inhibits invasion, metastasis, and proliferation of aggressive breast cancer cell lines such as HRas-transformed MCF10A and human breast cancer cell MDAMB231 In human MCF7 breast cancer cells, lycopene promotes Bax expression and caspase-9-induced apoptosis.³⁰

Fruits^31-34:

Some fruits, such as pomegranate, mangosteen, and citrus fruits, have been shown to suppress breast cancer cells.

Pomegranate:

Compounds containing pomegranate juice or parts can affect the metastatic circulation of breast cancer cells, as evidenced by inhibition of cell growth, improvement of cell adhesion and reduction of cell migration. The hydrophilicity of pomegranate seed oil was significantly reduced.

Mangosteen:

Phenols from the pericarp of mangosteen have been reported to induce major cyto-toxicities against MCF7 human breast cancer cells. Xanthone components isolated from the pericarp of mangosteen, including mangosteen, mangosteen, garcinone D and garcinone E, show a dose-dependent anti-aromatase effect in SKBR3 breast cancer cells, with mangosteen being the most potent. These effects were associated with increases in apoptotic cell death, antiproliferation and antiangiogenesis as mangostine induced apoptosis on BJMC3879 cells.

Apple:

Flavonoids isolated from the skins and tissues of Pink Lady apple inhibit the development of MCF7 malignant neoplasia cells and peeling apple juice has high polyphenol content and has an antiproliferative effect on MCF7 and MDAMB231 cells.As suggested by other reviews, the combination of quercetin-3βD-glucoside and apple extract showed a synergistic inhibitory effect on MCF7 cell proliferation.

Grape:

Red wine polyphenols were selectively cytotoxic to MCF7 cells, leading to membrane damage, mitochondrial dysfunction, and cell cycle arrest at the G2/M phase. Expression and localization, inhibition of fashion and NFκB expression and, the action of urokinase-type plasminogen activator (uPA), MMP2, and MMP9. Muscat skin extract also reduces cell invasion, cell migration, and bone regeneration of MCF7 cells.

Strawberry:

Strawberry methanol extract has also been shown to act on breast cancer cells. Inhibition of tumor cell proliferation in mice bearing mammary gland adenocarcinoma due to induction of cytotoxicity and apoptosis demonstrated in T47D breast cancer cells in vitro.

Cranberry:

It is consumed in the form of sauces, juices, fillings, or desserts, the popular superfood cranberries are rich in chemicals called polyphenols and have important effects on a variety of diseases, including breast cancer. Cranberry extract inhibits the growth of MCF7 cells. This is partly due to the induction of G1 apoptosis and cell cycle arrest.

Plum:

One study investigated the anticancer effects of smoky or plum, and immature plums were found against MDAMB231 cells by high concentrations of phenol and condensed tannins, decreased Bax and Bcl2 levels, and caspase and PARP cleavage. It was found to have a high cytotoxic effect.

Lemon:

In TNBC cell lines, naringin, a flavonoid abundantly introduced in the natural world of citrus, lowers cell proliferation and promotes cell apoptosis and G1 cycle capture. By adjusting the use of -catenin in in vitro and in vivo models, this has been established. Hesperidin, a flavonoid present in organic citrus products, has also been proven to stop MCF7GFP tubulin cells from growing. By up-regulating the expression of the bax and caspase3 genes while down-regulating the expression of the bcl2 gene, lemon citrus extracts triggered apoptosis in MCF7 cells with breast disease.

Barley:

Barley (Hordeum vulgare L.) is widely consumed all over the world. According to one study, young barley (barley plant grass) showed significant antiproliferative and prostatic activity when tested in vitro in rat breast tumor models and human breast cancer cells.

Sorghum:

Sorgham (Sorgham bicolor) is a primary grain that suppresses tumor growth and induces cell cycle arrest of malignant breast cells. In nude mice with breast cancer xenografts, metastasis was reduced via the Jak2/STAT pathway. In addition, 3-deoxyanthocyanins extracted from Red Sorghum Blanc exerted cytotoxicity against MCF7 cells and induced apoptosis mediated by regulation of the p53 gene and suppression of the Bcl2 gene.

Capsicum:

Red pepper is a popular spice that contains a certain amount of capsaicin (8-methyl Nvanillyl6nonenamide), which has been shown to have antiproliferative effects on breast cancer cells. 24-hour capsaicin treatment induced apoptosis in MCF7 cells in vitro via a caspathein-dependent pathway and induced apoptosis in MCF7 breast cancer cells associated with the induction of mitochondrial dysfunction.

Coumarin:

Coumarin is found in high concentrations in certain types of cinnamon. The mechanism of action of coumarins and their derivatives is generally caspase-dependent apoptosis. Coumarin, which is metabolized to 7-hydroxycoumarin by cytochromes CYP2A6 and 7-hydroxycoumarin, has an antiproliferative effect by reducing BCL expression in various tissues. BCL2 blocks oxygen-free radicals and suppresses the activation of caspase-9. This prolongs the life cycle of the cell and causes carcinogenesis. Caspase-9 is activated by Bax, and Bax overexpression regulates the release of mitochondrial cytochrome C in the cytoplasm. Cytochrome C in the cytoplasm activates caspases, causing activation of caspases 3,6,7. This breaks down important cytoplasm and nucleoproteins.

Camptothecin:

Camptothecin isolated from the wood and bark of Camptotheca acuminata. Camptothecin can trap topoisomerase I enzyme which is critically involved in DNA replication and transcription and form topoisomerase DNA complexes. This complex could cause cell death because it collides with an ongoing DNA (Takeshima et al., 2014) replication fork or transcription machinery. This mode of action develops camptothecin analogs, with aims to reduce toxicity and maintain anticancer activity. Two analogs of camptothecin were received from Food and Drug Administration (FDA) Topotecan and Irinotecan which are approved for various types of cancer including ovarian, lung, and breast cancer.

Epigallocatechin gallate:

It is included in green tea and known for its health benefits. In 2015, epigallocatechin gallate was reported to induce the expression of the epigenetically suppressed TIMP3 gene in the treatment of breast cancer. The TIMP3 gene was mediated through the regulation of epigenetic mechanisms involving EZH2 and class IHDAC independent of promoter DNA methylation. Treatment with EGCG results in decreased protein levels in class IHDAC and EZH2. Based on EGCG clinical studies in breast cancer, it also shows protection against the toxic side effects of chemotherapy and radiation therapy.

Ursolic Acid:

Ursolic Acid is a kind of sulfuric acid. It's made from a variety of herbs. Ursolic acid is a pentacyclic triterpenoid molecule that inhibits angiogenesis, proliferation, and cancer. Ursolic acid has apoptotic factors and signalling pathways, so it induces apoptosis and inhibits cell proliferation in MCF-7 breast cancer cells. Ursolic acid induces apoptosis in MCF-7 breast cancer cells to decrease cyclinD1/CDK4 expression by regulating Fox M1 (a transcription factor and a key for cell proliferation).

CONCLUSION:

Natural mixtures compounds are as yet viewed as a boundless wellspring in locating new vigorous chemotherapeutic experts, whilst giving the new idea premise to the disclosure of new constructions that may be supported as restorative specialists for an assortment of human illnesses. Although an impressive number of regular mixtures demonstrate helpful adequacy in preclinical investigations their variety abatements considerably till they come on the medical initial stage. The preference of the maximum appropriate in vitro and in vivo fashions that affirm the adequacy of the ordinary combos and assure their incorporation in medical preliminaries remains a check for scientists. To defeat those liabilities, there should be proposed non-obligatory in vitro and in silico techniques which could altogether decrease the time and prices wanted for the in vivo considers and to suppose the assets, specifically the economic ones, for the exam of bio compounds in medical preliminaries. By and large, the viability of regular mixtures is restricted by their low bioavailability. In this way, the analysts should zero in their examination not just on the adequacy of the build, which is of incredible interest, yet in addition on the medication conveyance frameworks ready to defeat its pharmacokinetic issues, simply as at the research of the best subordinates which carry some benefits concerning herbal accessibility and viability.

CONFLICT OF INTEREST:

The authors declare no conflict of interest, financial or otherwise.

ACKNOWLEDGMENTS:

We would like to thank the Managing Director of the I.T.M. University Gwalior, India, for encouraging us throughout the work.

REFERENCES:

1. Veeresham, C. Natural products derived from plants as a source of drugs. J. Adv. Pharm. Technol. Res. 2012; 3: 200–201.

2. Yuan, H.; Ma, Q.; Ye, L.; Piao, G. The traditional medicine and modern medicine from natural products. Molecules 2016; 21: 559.

3. Cragg, G.M.; Pezzuto, J.M. Natural products as a vital source for the discovery of cancer chemotherapeutic and chemopreventive agents. Med. Princ. Pract. 2016; 25 (Suppl 2): 41–59.

4. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J. Nat. Prod. 2020; 83: 770–803.

5. Seca, A.M.L.; Pinto, D.C.G.A. Plant secondary metabolites as anticancer agents: Successes in clinical trials and therapeutic application. Int. J. Mol. Sci. 2018; 19; 263.

6. Kotecha, R.; Takami, A.; Espinoza, J.L. Dietary phytochemicals and cancer chemoprevention: A review of the clinical evidence. Oncotarget 2016; 7: 52517–52529.

7. George, V.C.; Dellaire, G.; Rupasinghe, H.P.V. Plant flavonoids in cancer chemoprevention: Role in genome stability. J. Nutr. Biochem. 2017; 45: 1–14.

8. Thomford, N.E.; Senthebane, D.A.; Rowe, A.; Munro, D.; Seele, P.; Maroyi, A.; Dzobo, K. Natural products for drug discovery in the 21st century: Innovations for novel drug discovery. Int. J. Mol. Sci. 2018; 19: 1578.

9. Kucuk O, Sarkar FH, Sakr W, Djuric Z, Pollak MN, Khachik F, et al. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev. 2001; 10: 861–8.

10. Koh MS, Hwang JS, Moon AR. Lycopene inhibits proliferation, invasion and migration of human breast cancer cells. Biomol Ther. 2010;18:92–8. doi: 10.4062/biomolther.2010; 18:1.092.

11. Wang Y, Cui R, Xiao Y, Fang J, Xu Q. Effect of carotene and lycopene on the risk of prostate cancer: a systematic review and dose-response meta-analysis of observational studies. PLoS One. 2015; 10: e0137427. doi: 10.1371/journal.pone.0137427.

12. Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, et al. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res. 1999;59:1225–30.

13. Lin MC, Wang FY, Kuo YH, Tang FY. Cancer chemopreventive effects of lycopene: suppression of MMP-7 expression and cell invasion in human colon cancer cells. J Agric Food Chem. 2011; 59: 11304–18. doi: 10.1021/jf202433f.

14. Lian F, Wang XD. Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. Int J Cancer. 2008; 123: 1262–8. doi: 10.1002/ijc.23696.

15. Ono M, Takeshima M, Nakano S. Mechanism of the anticancer effect of lycopene (tetraterpenoids) Enzymes. 2015;37:139–66. doi: 10.1016/bs.enz.2015.06.002.

16. M, Diederich M. Antioxidant and anti-proliferative properties of lycopene. Free Radic Res. 2011; 45: 925–40. doi: 10.3109/10715762.2011.564168.

17. Petchsak P, Sripanidkulchai B. Momordica cochinchinensis aril extract induced apoptosis in human MCF-7 breast cancer cells. Asian Pac J Cancer Prev. 2015; 16: 5507–13. doi: 10.7314/APJCP.2015.16.13.5507.

18. Teodoro AJ, Oliveira FL, Martins NB, Maia Gde A, Martucci RB, Borojevic R. Effect of lycopene on cell viability and cell cycle progression in human cancer cell lines. Cancer Cell Int. 2012;12:36. doi: 10.1186/1475-2867-12-36.

19. Takeshima M, Ono M, Higuchi T, Chen C, Hara T, Nakano S. Anti-proliferative and apoptosis-inducing activity of lycopene against three subtypes of human breast cancer cell lines. Cancer Sci. 2014; 105: 252–7. doi: 10.1111/cas.12349.

20. Gloria NF, Soares N, Brand C, Oliveira FL, Borojevic R, Teodoro AJ. Lycopene and beta-carotene induce cell-cycle arrest and apoptosis in human breast cancer cell lines. Anticancer Res. 2014; 34: 1377–86.

21. Nahum A, Zeller L, Danilenko M, Prall OW, Watts CK, Sutherland RL, et al. Lycopene inhibition of IGF-induced cancer cell growth depends on the level of cyclin D1. Eur J Nutr. 2006; 45: 275–82. doi: 10.1007/s00394-006-0595-x.

22. Shindo S, Hosokawa Y, Hosokawa I, Ozaki K, Matsuo T. Genipin inhibits MMP-1 and MMP-3 release from TNF-a-stimulated human periodontal ligament cells. Biochimie. 2014; 107 Pt B:391–5. doi: 10.1016/j.biochi.2014.10.008.

23. Koriyama Y, Chiba K, Yamazaki M, Suzuki H, Muramoto K, Kato S. Long-acting genipin derivative protects retinal ganglion cells from oxidative stress models in vitro and in vivo through the Nrf2/antioxidant response element signaling pathway. J Neurochem. 2010; 115: 79–91. doi: 10.1111/j.

24. Yang X, Yao J, Luo Y, Han Y, Wang Z, Du L. P38 MAP kinase mediates apoptosis after genipin treatment in non-small-cell lung cancer H1299 cells via a mitochondrial apoptotic cascade. J Pharmacol Sci. 2013; 121: 272–81. doi: 10.1254/jphs.12234FP.

25. Pons DG, Nadal-Serrano M, Torrens-Mas M, Valle A, Oliver J, Roca P. UCP2 inhibition sensitizes breast cancer cells to therapeutic agents by increasing oxidative stress. Free Radic Biol Med. 2015; 86: 67–77. doi: 10.1016/j.freeradbiomed.2015.04.032.

26. Ayyasamy V, Owens KM, Desouki MM, Liang P, Bakin A, Thangaraj K, et al. Cellular model of Warburg effect identifies tumor promoting function of UCP2 in breast cancer and its suppression by genipin. PLoS One. 2011; 6: e24792. doi: 10.1371/journal.pone.0024792.

27. Chen PH, Peng CY, Pai HC, Teng CM, Chen CC, Yang CR. Denbinobin suppresses breast cancer metastasis through the inhibition of Src-mediated signaling pathways. J Nutr Biochem. 2011; 22: 732–40. doi: 10.1016/j.jnutbio.2010.06.004.]

28. Peiro G, Ortiz-Martínez F, Gallardo A, Pérez-Balaguer A, Sánchez-Payá J, Ponce JJ, et al. Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma. Br J Cancer. 2014; 111: 689–95. doi: 10.1038/bjc.2014.327.

29. Liu HE, Chang AS, Teng CM, Chen CC, Tsai AC, Yang CR. Potent anti-inflammatory effects of denbinobin mediated by dual inhibition of expression of inducible no synthase and cyclooxygenase 2. Shock. 2011;35:191–7. doi: 10.1097/SHK.0b013e3181f0e9a8.

30. Tsai AC, Pan SL, Lai CY, Wang CY, Chen CC, Shen CC, et al. The inhibition of angiogenesis and tumor growth by denbinobin is associated with the blocking of insulin-like growth factor-1 receptor signaling. J Nutr Biochem. 2011; 22: 625–33. doi: 10.1016/j.jnutbio.2010.04.014.

31. Chen J, Hou R, Zhang X, Ye Y, Wang Y, Tian J. Calycosin suppresses breast cancer cell growth via ERβ-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways. PLoS One. 2014;9:912-45. doi: 10.1371 0091245.

32. Huang G, Li M. The role of EphB4 and IGF-IR expression in breast cancer cells. Int J Clin Exp Pathol. 2015; 8: 5997–6004.

33. Kim S, Moon A. Capsaicin-induced apoptosis of H-ras-transformed human breast epithelial cells is Rac-dependent via ROS generation. Arch Pharm Res. 2004; 27: 845–9. doi: 10.1007/BF02980177.

34. Kang HJ, Soh Y, Kim MS, Lee EJ, Surh YJ, Kim HR, et al. Roles of JNK-1 and p38 in selective induction of apoptosis by capsaicin in ras-transformed human breast epithelial cells. Int J Cancer. 2003; 103: 475–82. doi: 10.1002/ijc.10855.

Received on 27.04.2023 Modified on 13.06.2023

Res. J. Pharmacognosy and Phytochem. 2023; 15(4):305-310.

DOI: 10.52711/0975-4385.2023.00048